Literature DB >> 11414287

Transforming growth factor-alpha precursors in human colon carcinoma cells.

M Asbert1, B Montaner, R Pérez-Tomás.   

Abstract

Among the proteins of the epidermal growth factor family, transforming growth factor-alpha (TGF-alpha) may be an especially reliable indicator of metastasis or prognosis in human colorectal carcinomas. Moreover, anomalous forms of TGF-alpha have been detected in several tissues of cancer origin, suggesting a role of these forms in the development of the disease. This study was designed to identify the presence of TGF-alpha precursors in different colon cancer cell lines by mean of immunocytochemistry and western blotting techniques. Pro-TGF-alpha was detected in all cell lines tested. Staining for pro-TGF-alpha was observed in cytoplasm. Monoclonal antibody to TGF-alpha detected two bands of 20 and 21 kDa. Polyclonal antibody to pro-TGF-alpha revealed five bands ranging from 15 to 24 kDa. All these proteins were also detected in nonmalignant cells expressing a transfected rat pro-TGF-alpha gene. In conclusions, transformation in these human colon carcinoma cells is not due to the presence of anomalous forms of TGF-alpha precursors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11414287     DOI: 10.1023/a:1010634506440

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  Increased transforming growth factor-alpha levels in human colon carcinoma cell lines over-expressing protein kinase C.

Authors:  P Maruvada; A E Levine
Journal:  Int J Cancer       Date:  1999-01-05       Impact factor: 7.396

2.  Growth modulation of mouse keratinocytes by transforming growth factors.

Authors:  R J Coffey; N J Sipes; C C Bascom; R Graves-Deal; C Y Pennington; B E Weissman; H L Moses
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

3.  Analysis of growth factor-dependent signalling in human epithelioid sarcoma cell lines. clues To the role of autocrine, juxtacrine and paracrine interactions in epithelioid sarcoma.

Authors:  C D Gerharz; U Ramp; P Reinecke; C Schardt; U Friebe; M Déjosez; T Nitsch; H E Gabbert
Journal:  Eur J Cancer       Date:  2000-06       Impact factor: 9.162

4.  Modulation of a high molecular weight form of transforming growth factor-alpha in human colon carcinoma cell lines.

Authors:  L F Watkins; M G Brattain; A E Levine
Journal:  Cancer Lett       Date:  1988-05       Impact factor: 8.679

5.  Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process.

Authors:  A Pandiella; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

6.  Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation.

Authors:  P Anklesaria; J Teixidó; M Laiho; J H Pierce; J S Greenberger; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

7.  Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.

Authors:  R J Coffey; A S Goustin; A M Soderquist; G D Shipley; J Wolfshohl; G Carpenter; H L Moses
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

8.  Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor.

Authors:  T S Bringman; P B Lindquist; R Derynck
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

9.  EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma.

Authors:  C Messa; F Russo; M G Caruso; A Di Leo
Journal:  Acta Oncol       Date:  1998       Impact factor: 4.089

10.  Human colon cancer cell lines secrete alpha TGF-like activity.

Authors:  A R Hanauske; J Buchok; W Scheithauer; D D Von Hoff
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

View more
  1 in total

1.  A novel predictive strategy by immunohistochemical analysis of four EGFR ligands in metastatic colorectal cancer treated with anti-EGFR antibodies.

Authors:  Michihiro Yoshida; Takaya Shimura; Mikinori Sato; Masahide Ebi; Takahiro Nakazawa; Hiromitsu Takeyama; Takashi Joh
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-26       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.